In the evolving landscape of sleep medicine in 2026, the pharmacological approach to insomnia has become increasingly specialized. While newer classes of drugs, such as Dual Orexin Receptor Antagonists (DORAs), have revolutionized the treatment of “sleep-onset” and “sleep-maintenance” insomnia by targeting wakefulness pathways, a critical…